Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 182.07
+2.07 (1.15%)
Jan 7, 2026, 11:50 AM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 239.01 billion as of January 6, 2026. Its market cap has decreased by -30.82% in one year.
Market Cap
239.01B
Enterprise Value
280.08B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
182.07
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 239.01B, an increase of 5.42%. That is a compound annual growth rate of 1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 237.50B | 3.86% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |